Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type

Journal of Clinical Oncology

Volumn 25, Issue 15, 2007, Pages 2042-2048

  Zighelboim, Israel ^a   Goodfellow, Paul J ^a   Gao, Feng ^a   Gibb, Randall K ^a   Powell, Matthew A ^a   Rader, Janet S ^a   Mutch, David G ^a  

^a USA

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MLH1; MICROSATELLITE DNA; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN MSH2; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; EPIGENETICS; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN METHYLATION; COHORT ANALYSIS; DNA METHYLATION; DNA REPAIR; ENDOMETRIUM TUMOR; GENETIC EPIGENESIS; GENETICS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARCINOMA, ENDOMETRIOID; COHORT STUDIES; DNA METHYLATION; DNA REPAIR; ENDOMETRIAL NEOPLASMS; EPIGENESIS, GENETIC; FEMALE; HUMANS; MICROSATELLITE INSTABILITY; MICROSATELLITE REPEATS; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES;

EID: 34249949422     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.08.2107     Document Type: Article

References (44)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin 56:106-130, 2006
2. Shiozawa T, Konishi I: Early endometrial carcinoma: Clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment. Int J Clin Oncol 11:13-21, 2006
3. Risinger JI, Berchuck A, Kohler MF, et al: Genetic instability of microsatellites in endometrial carcinoma. Cancer Res 53:5100-5103, 1993
4. Lax SF: Molecular genetic pathways in various types of endometrial carcinoma: From a phenotypical to a molecular-based classification. Virchows Arch 444:213-223, 2004
5. Kane MF, Loda M, Gaida GM, et al: Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57:808-811, 1997
6. Esteller M, Levine R, Baylin SB, et al: MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene 17:2413-2417, 1998
7. Simpkins SB, Bocker T, Swisher EM, et al: MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Hum Mol Genet 8:661-666, 1999
8. Goodfellow PJ, Buttin BM, Herzog TJ, et al: Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. Proc Natl Acad Sci U S A 100:5908-5913, 2003
9. Thibodeau SN, Bren G, Schaid D: Microsatellite instability in cancer of the proximal colon. Science 260:816-819, 1993
10. Kim H, Jen J, Vogelstein B, et al: Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 145:148-156, 1994
11. Dolcetti R, Viel A, Doglioni C, et al: High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol 154:1805-1813, 1999
12. Sankila R, Aaltonen LA, Jarvinen HJ, et al: Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology 110:682-687, 1996
13. Lynch HT, Smyrk T: Colorectal cancer, survival advantage, and hereditary nonpolyposis colorectal carcinoma. Gastroenterology 110:943-954, 1996
14. Gryfe R, Kim H, Hsieh ET, et al: Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342:69-77, 2000
15. Kobayashi K, Sagae S, Kudo R, et al: Microsatellite instability in endometrial carcinomas: Frequent replication errors in tumors of early onset and/or of poorly differentiated type. Genes Chromosomes Cancer 14:128-132, 1995
16. Caduff RF, Johnston CM, Svoboda-Newman SM, et al: Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma. Am J Pathol 148:1671-1678, 1996
17. Catasus L, Machin P, Matias-Guiu X, et al: Microsatellite instability in endometrial carcinomas: Clinicopathologic correlations in a series of 42 cases. Hum Pathol 29:1160-1164, 1998
18. Tibiletti MG, Furlan D, Taborelli M, et al: Microsatellite instability in endometrial cancer: Relation to histological subtypes. Gynecol Oncol 73:247-252, 1999
19. Wong YF, Ip TY, Chung TK, et al: Clinical and pathologic significance of microsatellite instability in endometrial cancer. Int J Gynecol Cancer 9:406-410, 1999
20. Basil JB, Goodfellow PJ, Rader JS, et al: Clinical significance of microsatellite instability in endometrial carcinoma. Cancer 89:1758-1764, 2000
21. MacDonald ND, Salvesen HB, Ryan A, et al: Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas. Cancer Res 60:1750-1752, 2000
22. Fiumicino S, Ercoli A, Ferrandina G, et al: Microsatellite instability is an independent indicator of recurrence in sporadic stage I-II endometrial adenocarcinoma. J Clin Oncol 19:1008-1014, 2001
23. Maxwell GL, Risinger JI, Alvarez AA, et al: Favorable survival associated with microsatellite instability in endometrioid endometrial cancers. Obstet Gynecol 97:417-422, 2001
24. Baldinu P, Cossu A, Manca A, et al: Microsatellite instability and mutation analysis of candidate genes in unselected Sardinian patients with endometrial carcinoma. Cancer 94:3157-3168, 2002
25. Muresu R, Sini MC, Cossu A, et al: Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer. Eur J Cancer 38:1802-1809, 2002
26. Orbo A, Eklo K, Kopp M: A semiautomated test for microsatellite instability and its significance for the prognosis of sporadic endometrial cancer in northern Norway. Int J Gynecol Pathol 21:27-33, 2002
27. Pijnenborg JM, Dam-de Veen GC, de Haan J, et al: Defective mismatch repair and the development of recurrent endometrial carcinoma. Gynecol Oncol 94:550-559, 2004
28. Black D, Soslow RA, Levine DA, et al: Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma. J Clin Oncol 24:1745-1753, 2006
29. Peiffer SL, Herzog TJ, Tribune DJ, et al: Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res 55:1922-1926, 1995
30. Kowalski LD, Mutch DG, Herzog TJ, et al: Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancers. Genes Chromosomes Cancer 18:219-227, 1997
31. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988
32. Lahiri DK, Nurnberger JI Jr: A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444, 1991
33. Boland CR, Thibodeau SN, Hamilton SR, et al: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257, 1998
34. Xiong Z, Laird PW: COBRA: A sensitive and quantitative DNA methylation assay. Nucleic Acids Res 25:2532-2534, 1997
35. Whitcomb BP, Mutch DG, Herzog TJ, et al: Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma. Clin Cancer Res 9:2277-2287, 2003
36. Fine JP, Gray RJ: A proportional hazards model for the sub-distribution of a competing risk. J Am Stat Assoc 94:496-509, 1999
37. Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10-17, 1983
38. Morrow CP, Bundy BN, Kurman RJ, et al: Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecol Oncol 40:55-65, 1991
39. Keys HM, Roberts JA, Brunetto VL, et al: A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study. Gynecol Oncol 92:744-751, 2004
40. Amant F, Moerman P, Neven P, et al: Endometrial cancer. Lancet 366:491-505, 2005
41. Risinger JI, Maxwell GL, Chandramouli GV, et al: Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling. Cancer Res 65:5031-5037, 2005
42. Whelan AJ, Babb S, Mutch DG, et al: MSI in endometrial carcinoma: Absence of MLH1 promoter methylation is associated with increased familial risk for cancers. Int J Cancer 99:697-704, 2002
43. Buttin BM, Powell MA, Mutch DG, et al: Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation. Clin Cancer Res 10:481-490, 2004
44. Hampel H, Frankel W, Panescu J, et al: Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 66:7810-7817, 2006